Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis

Eur J Anaesthesiol. 2016 Jan;33(1):6-13. doi: 10.1097/EJA.0000000000000252.

Abstract

Background: Isoflurane has shown better control of intensive care sedation than propofol or midazolam and seems to be a useful alternative. However, its effect on survival remains unclear.

Objective: The objective of this study is to compare mortality after sedation with either isoflurane or propofol/midazolam.

Design: A retrospective analysis of data in a hospital database for a cohort of consecutive patients.

Setting: Sixteen-bed interdisciplinary surgical ICU of a German university hospital.

Patients: Consecutive cohort of 369 critically ill surgical patients defined within the database of the hospital information system. All patients were continuously ventilated and sedated for more than 96 h between 1 January 2005 and 31 December 2010. After excluding 169 patients (93 >79 years old, 10 <40 years old, 46 mixed sedation, 20 lost to follow-up), 200 patients were studied, 72 after isoflurane and 128 after propofol/midazolam.

Interventions: Sedation with isoflurane using the AnaConDa system compared with intravenous sedation with propofol or midazolam.

Main outcome measures: Hospital mortality (primary) and 365-day mortality (secondary) were compared with the Kaplan-Meier analysis and a log-rank test. Adjusted odds ratios (ORs) [with 95% confidence interval (95% CI)] were calculated by logistic regression analyses to determine the risk of death after isoflurane sedation.

Results: After sedation with isoflurane, the in-hospital mortality and 365-day mortality were significantly lower than after propofol/midazolam sedation: 40 versus 63% (P = 0.005) and 50 versus 70% (P = 0.013), respectively. After adjustment for potential confounders (coronary heart disease, chronic obstructive pulmonary disease, acute renal failure, creatinine, age and Simplified Acute Physiology Score II), patients after isoflurane were at a lower risk of death during their hospital stay (OR 0.35; 95% CI 0.18 to 0.68, P = 0.002) and within the first 365 days (OR 0.41; 95% CI 0.21 to 0.81, P = 0.010).

Conclusion: Compared with propofol/midazolam sedation, long-term sedation with isoflurane seems to be well tolerated in this group of critically ill patients after surgery.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anesthetics, Inhalation / administration & dosage
  • Anesthetics, Intravenous / administration & dosage
  • Critical Illness
  • Female
  • Germany
  • Hospital Mortality
  • Hospitals, University
  • Humans
  • Hypnotics and Sedatives / administration & dosage*
  • Intensive Care Units
  • Isoflurane / administration & dosage*
  • Kaplan-Meier Estimate
  • Male
  • Midazolam / administration & dosage*
  • Middle Aged
  • Propofol / administration & dosage*
  • Retrospective Studies
  • Survival Rate

Substances

  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Hypnotics and Sedatives
  • Isoflurane
  • Midazolam
  • Propofol